A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer

Joel Picus, Susan Halabi, W. Kevin Kelly, Nicholas J. Vogelzang, Young E. Whang, Ellen B. Kaplan, Walter M. Stadler, Eric J. Small

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences